{"filings":[{"id":555441,"accession_number":"0000072331-26-000022","cik":72331,"company_name":"NORDSON CORP","ticker":"NDSN","form_type":"8-K","filed_at":"2026-05-20T20:33:44+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Nordson Q2 record sales $741M (+8% YoY) and adj EPS $2.86 (+18% YoY); raises FY outlook","event_type":"earnings","confidence":"high","bullets":["Net income $117M, $2.09 diluted EPS; adjusted diluted EPS $2.86 (record, +18% YoY).","Revenue $741M (record Q2), organic growth 7% and favorable FX 3%; all segments up.","Segments: Industrial Precision Solutions $350M (+10%), Medical & Fluid Solutions $213M (+5%), Advanced Technology Solutions $178M (+10%).","Backlog up 18% YoY; Q3 sales guidance $760-790M, adj EPS $2.95-3.15; FY guidance raised to $2.93-3.01B revenue, adj EPS $11.30-11.80.","Acquired CapstanAG Systems (precision agriculture) in March; small bolt-on."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":114036,"accession_number":"0000072331-26-000017","cik":72331,"company_name":"NORDSON CORP","ticker":"NDSN","form_type":"8-K","filed_at":"2026-03-04T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Nordson shareholders elect three directors, ratify auditor, approve advisory say-on-pay","event_type":"other_material","confidence":"high","bullets":["Christopher Mapes, Michael Merriman Jr., Sundaram Nagarajan elected to board until 2029; all received >42M votes for.","Ernst & Young LLP ratified as auditor for FY ending Oct 31, 2026; 49.58M for, 1.35M against.","Advisory vote on named executive officer compensation approved with 44.11M for, 2.27M against, 4.51M broker non-votes.","Meeting quorum of 51.06M shares (91.66% of outstanding) present."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":114035,"accession_number":"0000072331-26-000011","cik":72331,"company_name":"NORDSON CORP","ticker":"NDSN","form_type":"8-K","filed_at":"2026-02-18T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Nordson Q1 record sales $669M (+9% YoY); raises FY adj. EPS guidance to $11.00-$11.60","event_type":"earnings","confidence":"high","bullets":["Q1 GAAP EPS $2.38 (up 44% YoY); adjusted EPS $2.37 (record, up 15%).","Advanced Technology Solutions sales $149M (+23% YoY) led by electronics dispense and x-ray.","Backlog grew ~4% YoY; Q2 guidance: sales $710-$740M, adj. EPS $2.70-$2.90.","Full-year sales outlook raised to $2,860-$2,980M; adj. EPS raised to $11.00-$11.60.","Non-cash gain on minority tech investment boosted GAAP earnings; EBITDA $203M (30% of sales)."],"consensus_eps_estimate":null,"consensus_eps_actual":2.38,"consensus_revenue_estimate":null,"consensus_revenue_actual":669461000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":114034,"accession_number":"0000072331-26-000005","cik":72331,"company_name":"NORDSON CORP","ticker":"NDSN","form_type":"8-K","filed_at":"2026-02-02T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Nordson enters $1.2B revolving credit facility, repays $248M term loans","event_type":"debt","confidence":"high","bullets":["New $1.2B senior unsecured multicurrency revolving credit facility matures January 30, 2031.","Proceeds used to repay $248M of outstanding term loans under prior credit facility.","Includes $85M letter of credit subfacility, $100M swingline subfacility, $425M multicurrency sublimit.","Facility amends and restates prior $1.2B credit agreement dated June 6, 2023.","Borrowings available in USD, EUR, GBP, CHF, SGD, JPY and other approved currencies."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":130433,"accession_number":"0000072331-25-000138","cik":72331,"company_name":"NORDSON CORP","ticker":"NDSN","form_type":"8-K","filed_at":"2025-12-10T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Nordson reports record FY2025 sales of $2.8B; adj. EPS $10.24, up 5% YoY","event_type":"earnings","confidence":"high","bullets":["Q4 sales $752M (+1% YoY); diluted EPS $2.69; adj. diluted EPS $3.03 (+9% YoY).","FY2025 record sales $2.8B (+4%); net income $484M ($8.51 diluted EPS); adj. EPS $10.24.","Medical & Fluid Solutions sales up 10% YoY; Industrial Precision down 2%; Advanced Tech down 4%.","FY2026 guidance: sales $2.83B-$2.95B; adj. EPS $10.80-$11.50; backlog ~$600M (+5% ex-divestiture).","Record free cash flow $661M (136% conversion); EBITDA margin 32% for FY2025."],"consensus_eps_estimate":null,"consensus_eps_actual":8.51,"consensus_revenue_estimate":null,"consensus_revenue_actual":2791687000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":130432,"accession_number":"0000072331-25-000125","cik":72331,"company_name":"NORDSON CORP","ticker":"NDSN","form_type":"8-K","filed_at":"2025-10-28T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Nordson adopts Executive Severance Policy effective November 1, 2025","event_type":"other","confidence":"high","bullets":["Policy provides severance benefits for US-based executive officers on qualifying termination outside change-in-control period.","Benefits include lump-sum salary, prorated bonus, COBRA for 12 months, outplacement up to $10,000, and equity per plan.","CEO Sundaram Nagarajan excluded due to existing employment agreement with separate severance terms.","Severance conditioned on release of claims and compliance with non-compete, non-solicitation, and confidentiality covenants.","Policy administered by Compensation Committee; subject to amendment/termination with no impairment of existing qualifying terminations."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":146979,"accession_number":"0000072331-25-000112","cik":72331,"company_name":"NORDSON CORP","ticker":"NDSN","form_type":"8-K","filed_at":"2025-08-20T23:59:59+00:00","items":["2.02","7.01","8.01","9.01"],"status":"ready","headline":"Nordson Q3 sales $742M (+12%), adjusted EPS $2.73 (+13%); board adds $500M buyback","event_type":"earnings","confidence":"high","bullets":["Q3 sales $742M, up 12% YoY; organic sales up 2%; acquisition impact 8%.","Adjusted EPS $2.73, up 13% from $2.41; GAAP EPS $2.22.","Advanced Technology Solutions organic sales up 15%; Medical & Fluid up 32% (incl. Atrion).","Board authorized $500M share repurchase; total authorization ~$793M.","Full-year guidance confirmed: sales slightly below midpoint, adjusted EPS slightly above."],"consensus_eps_estimate":null,"consensus_eps_actual":5.83,"consensus_revenue_estimate":null,"consensus_revenue_actual":2039867000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":146978,"accession_number":"0000072331-25-000088","cik":72331,"company_name":"NORDSON CORP","ticker":"NDSN","form_type":"8-K","filed_at":"2025-07-14T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Nordson appoints Joseph M. Rutledge as VP and Chief Accounting Officer","event_type":"leadership","confidence":"high","bullets":["Joseph M. Rutledge appointed VP and Chief Accounting Officer effective July 14, 2025.","Stephen Shamrock ceased as VP and CAO and separated from company on July 10, 2025.","Rutledge previously served as VP and assistant controller at Eaton Corporation (ETN) for 15 years.","No family relationships or reportable transactions with Rutledge disclosed.","Rutledge will oversee Nordson's accounting operations and financial reporting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":165472,"accession_number":"0000072331-25-000074","cik":72331,"company_name":"NORDSON CORP","ticker":"NDSN","form_type":"8-K/A","filed_at":"2025-06-11T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Nordson separation agreement for departing segment leader Lovass: $832,759 cash, continued vesting","event_type":"leadership","confidence":"high","bullets":["Stephen Lovass ceased as Medical and Fluid Solutions segment leader; assists transition until June 1, 2025, then separates.","Receives $832,759 cash (severance plus COBRA) and pro-rata FY2025 annual incentive under separation agreement.","Stock options granted on/before Dec 1, 2022 continue vesting; exercisable until June 1, 2030 or original expiry.","Restricted shares/units from same period vest pro-rata; PSUs from Dec 1, 2022 vest pro-rata based on actual performance.","One-year non-compete, non-solicitation; indefinite confidentiality, non-disparagement; outplacement up to $10k, financial planning up to $5k."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":165474,"accession_number":"0000072331-25-000053","cik":72331,"company_name":"NORDSON CORP","ticker":"NDSN","form_type":"8-K","filed_at":"2025-05-28T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Nordson Q2 FY2025 sales $683M (+5%), adj EPS $2.42 beats midpoint; Q3 guide $710-750M","event_type":"earnings","confidence":"high","bullets":["Q2 sales $683M (+5% YoY) with 8% acquisition benefit offset by 2% organic decline.","Reported EPS $1.97 vs $2.05 prior year; adjusted EPS $2.42 (+3% YoY) above guidance midpoint.","Advanced Technology Solutions organic sales +18% YoY; Medical & Fluid Solutions +20% (incl. Atrion).","Q3 guidance: sales $710-$750M, adjusted EPS $2.55-$2.75 per diluted share.","Backlog grew ~5% sequentially; company repurchased $85M in shares during the quarter."],"consensus_eps_estimate":2.4072,"consensus_eps_actual":3.62,"consensus_revenue_estimate":null,"consensus_revenue_actual":1298358000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl+finnhub","sentiment":"neutral","materiality_score":0.75,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}